Clinical Trial: 20287

Trial Status: Open
Disease Type: Leukemia
Trial ID 20287
Sponsor ID APG115AU101

A Phase Ib/II Study of APG-115 Alone or in Combination With Azacitidine in Patients with Relapsed/Refractory AML

Principal Investigator
Mitul Gandhi, MD
1 Location


Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID 21287
Sponsor ID Novartis

A phase Ib/II open label dose confirmation, proof of concept study of siremadlin in combination with venetoclax plus azacitidine in unfit adult AML participants who responded sub-optimally to first-line venetoclax plus azacitidine treatment and in participants with newly diagnosed unfit AML presenting with high-risk clinical features (CHDM201I12201)

Principal Investigator
Mitul Gandhi, MD
1 Location
Trial ID DR-01-ONC-001
Sponsor ID Dren Bio

A Multicenter, Open-Label, First-in-Human, Multiple Expansion Cohort, Phase 1/2 Study to Evaluate the Safety and Efficacy of DR-01 in Adult Subjects with Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas